Latest filing published 05 Jul 2021 for Ferrexpo plc, €947.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -71.8%Entry £4.35 · Close at T+365 £1.22
- -56.9%Entry £4.06 · Close at T+365 £1.75
- -17.0%Entry £2.91 · Close at T+365 £2.42
- +88.9%Entry £1.73 · Close at T+365 £3.27
- +125.0%Entry £1.73 · Close at T+365 £3.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Roman Palyvoda: trading record in brief
Roman Palyvoda discloses dealings in Ferrexpo plc to RNS (LSE). Over a trading history stretching from 1 April 2020 to 2 July 2021, the count stands at 7 filings.
Every open-market trade on record is a purchase: 7 purchases worth €25k, and no sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €908. Of 6 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 6 purchases show a median change of +32.3%, with the price up in 83% of them. These figures describe past trades and do not predict future prices.
Most recently, on 5 July 2021, the filings show an open-market purchase worth €947 in Ferrexpo plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Roman Palyvoda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 188 shares@ £4.3353.7% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:4034551-2Canonical exit: 30 Sept 2021 (T+90)
- 597 shares@ £3.86110.4% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3947672-2Canonical exit: 15 Jul 2021 (T+90)
- 263 shares@ £2.92533.4% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3862584-2Canonical exit: 28 Apr 2021 (T+90)
- 222 shares@ £1.77531.7% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3744184-2Canonical exit: 7 Jan 2021 (T+90)
- 213 shares@ £1.817100.0% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3703216-3Canonical exit: 25 Nov 2020 (T+90)
- 14,598 shares@ £1.21597.9% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3559173-4Canonical exit: 5 Jul 2020 (T+90)
- 15,000 sharesOutside a trading venueISIN GB00B1XH2C03FCA-NSM:3554823-4Canonical exit: 30 Jun 2020 (T+90)
7 of 7 declarations